This meeting will discuss guidance and regulation in the EU for assuring pharmaceutical product sterility through aseptic manufacturing. It will look at a holistic approach for ensuring product sterility using quality risk-management principles. The discussion will include information on EU GMP Annex 1 and environmental controls.
